Of the 28 patients with recurrent CRC, 67.9% (19/28, 95% CI 48–84%) and 32.1% (9/28, 95% CI 16–52%) were positive for methylated BCAT1/IKZF1 DNA and CEA, respectively. This evidence concerns the gene CEACAM5 and colorectal carcinoma.